Charles River Laboratories International Inc
CRL: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| rNc | LOCK|S@ | LOCK|G@%>&# |
Charles River Earnings: Stock Falls Amid Challenging Environment and Sequential Cancellations
Charles River's second-quarter revenue of $1.03 billion represented an increase of 0.6% compared with the prior-year period. Management raised its full-year revenue outlook, now expecting a 1.5% decline at the midpoint compared with 2024, versus its prior guidance of negative 4.5% at the midpoint.
